Cerevast Therapeutics competitorsClear all

Cerevast Therapeutics's top competitors include Intersect ENT, Pressure BioSciences and SteadyMed Therapeutics.
Cerevast Therapeutics
Cerevast Therapeutics
Cerevast Therapeutics is a medical technology company developing treatments for acute ischemic stroke and other vascular disorders.
Intersect ENT
Intersect ENT
Intersect ENT provides therapy solutions that enable ENT physicians to improve the quality of life of patients.
Pressure BioSciences
Pressure BioSciences
Pressure bioscience is focused on developing, marketing and selling proprietary laboratory instrumentation and associated consumables.
SteadyMed Therapeutics
SteadyMed Therapeutics
SteadyMed Therapeutics is a medical device company pursuing innovative devices for delivering injectable therapeutic drugs for pain relief, diabetes, and other chronic conditions.
Founding Date
Founding Date
2015
Founding Date
2003
Founding Date
2004
Founding Date
2005
Type
Type
Private
Type
Public
Type
Public
Type
Subsidiary
Tags
Locations
Locations
Bothell, US HQ
Locations
Menlo Park, US HQ
Locations
Easton, US HQ
Medford, US
Locations
San Ramon, US HQ
Rehovot, IL
Employees
Employees
7
Employees
4022% increase
Employees
1721% increase
Employees
811% decrease
Valuation ($)
Valuation ($)
N/A
Valuation ($)
527.2 m
Valuation ($)
5.4 m
Valuation ($)
N/A
Twitter followers
Twitter followers
20
Twitter followers
938
Twitter followers
1.2 k
Twitter followers
87
Number of tweets (last 30 days)
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
3
Number of tweets (last 30 days)
1
Number of tweets (last 30 days)
N/A
Alexa Website Rank
Alexa Website Rank
405398
Alexa Website Rank
462379
Alexa Website Rank
338893
Alexa Website Rank
N/A
Employee Rating
Employee Rating
N/A
Employee Rating
2.7
Employee Rating
N/A
Employee Rating
4.4

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
$109.1m (FY, 2019)
Revenue (est.)
$1.8m (FY, 2019)
Revenue (est.)
$1.1m (FY, 2017)
Cost of goods
Cost of goods
N/A
Cost of goods
$21.8m (FY, 2019)
Cost of goods
$1.2m (FY, 2019)
Cost of goods
N/A
Gross profit
Gross profit
N/A
Gross profit
$87.4m (FY, 2019)
Gross profit
$612.9k (FY, 2019)
Gross profit
N/A
Net income
Net income
N/A
Net income
($43m) (FY, 2019)
Net income
($15.9m) (FY, 2019)
Net income
N/A

Funding

Total funding raised
Total funding raised
$ 22.4m
Total funding raised
$ 102.9m
Total funding raised
$ 4.9m
Total funding raised
$ 35m
For sources of this data, please see the company profile

View company profiles

Intersect ENT
HQ
Menlo Park, US
Employees
402↑ 2% increase

Intersect ENT provides therapy solutions that enable ENT physicians to improve the quality of life of patients.

View company
Pressure BioSciences
HQ
Easton, US
Employees
17↑ 21% increase

Pressure bioscience is focused on developing, marketing and selling proprietary laboratory instrumentation and associated consumables.

View company
SteadyMed Therapeutics
HQ
San Ramon, US

SteadyMed Therapeutics is a medical device company pursuing innovative devices for delivering injectable therapeutic drugs for pain relief, diabetes, and other chronic conditions.

View company